CureApp
Last updated: June 14, 2024
CEO Kohta Satake
Japan | Funding: ¥13.3B (+)
Website: https://cureapp.co.jp/
CureApp is involved in the research and development of prescription and non-prescription digital therapeutics applications. CureApp's prescription DTx app is used for the treatment of hypertension.
Website: https://cureapp.co.jp/
CureApp is involved in the research and development of prescription and non-prescription digital therapeutics applications. CureApp's prescription DTx app is used for the treatment of hypertension.